The safety and efficacy of investigational agents and/or investigational uses of approved products have not been established.
Our platform includes lumateperone, follow-on compounds, and alternative formulations, including a long-acting injectable. Lumateperone is being studied for the treatment of major depressive disorder, and other neuropsychiatric and neurological disorders.